đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to determine the safety of long term use of TA...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01452776
The purpose of this study is to determine the pharmacokinetics (PK) of TAK-...
Status
Completed
Location
Zhongshan Hospital Fudan University
Start Date
2017-04-19
Trial ID
NCT03085836
Treatments Being Tested
The primary purpose of this study was to evaluate the safety, tolerability,...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT02141698
Treatments Being Tested
The purpose of this study is to investigate the safety and efficacy of long...
Status
Completed
Location
Takeda Selected Site
Start Date
2016-09-01
Trial ID
NCT03214198
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of oral T...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-15
Trial ID
NCT02954848
Treatments Being Tested
The purpose of this study was to evaluate the safety and pharmacokinetics o...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT02123953
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of TAK-438, once dail...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01452750
The purpose of this survey is to evaluate the safety and effectiveness of l...
Status
Completed
Location
Takeda Selected Site
Start Date
2016-03-01
Trial ID
NCT03214081
Treatments Being Tested
The purpose of this study is to confirm the efficacy of TAK-438, once daily...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01459367
Treatments Being Tested
This is a comparative study of vonoprazan (TAK-438) (10 mg or 20 mg) in par...
Status
Completed
Location
Beijing Chao Yang Hospital
Start Date
2015-04-01
Trial ID
NCT02388737
Treatments Being Tested